90 related articles for article (PubMed ID: 2389038)
1. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.
Luyten PR; Marien AJ; Heindel W; van Gerwen PH; Herholz K; den Hollander JA; Friedmann G; Heiss WD
Radiology; 1990 Sep; 176(3):791-9. PubMed ID: 2389038
[TBL] [Abstract][Full Text] [Related]
2. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.
Kwee SA; Coel MN; Lim J; Ko JP
J Neuroimaging; 2004 Jul; 14(3):285-9. PubMed ID: 15228773
[TBL] [Abstract][Full Text] [Related]
3. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
6. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
7. Brain tumors: detection and typing by use of CPMG sequences and in vivo T2 measurements.
Rinck PA; Meindl S; Higer HP; Bieler EU; Pfannenstiel P
Radiology; 1985 Oct; 157(1):103-6. PubMed ID: 4034954
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
[TBL] [Abstract][Full Text] [Related]
9. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography.
Tovi M; Lilja A; Bergström M; Ericsson A; Bergström K; Hartman M
Acta Radiol; 1990 Sep; 31(5):417-29. PubMed ID: 2261284
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
[TBL] [Abstract][Full Text] [Related]
11. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
Tien RD; Lai PH; Smith JS; Lazeyras F
AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic imaging of human brain tumors: H-1 chemical shift imaging and PET].
Koga M; Yoshikawa K; Obata T; Mizoe J; Tsujii H; Ikehira H; Shishido F
Nihon Rinsho; 1997 Jul; 55(7):1774-8. PubMed ID: 9233025
[TBL] [Abstract][Full Text] [Related]
13. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
14. [1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia].
Felber SR
Radiologe; 1993 Nov; 33(11):626-32. PubMed ID: 8278589
[TBL] [Abstract][Full Text] [Related]
15. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
17. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
Luan W; Zhang J
Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance in the study of cerebral gliomas].
Vaghi MA; Visciani A; Passerini A; Longone V; Broggi G
Radiol Med; 1986 Jun; 72(6):431-8. PubMed ID: 3012662
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas.
Porto L; Kieslich M; Franz K; Lehrbecher T; Pilatus U; Hattingen E
Brain Tumor Pathol; 2010 Oct; 27(2):65-70. PubMed ID: 21046307
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]